Nitric Oxide Inhalation Therapy for Myocardial Ischemia in Patients With Coronary Artery Disease View Homepage


Ontology type: schema:MedicalStudy     


Clinical Trial Info

YEARS

2001-2003

ABSTRACT

This study will test whether inhaling nitric oxide gas can improve blood flow to the heart, ventricular function, exercise tolerance in patients with coronary artery disease and chest pain that has not improved with medical or surgical therapy. Patients with coronary artery disease who have chest pain despite treatment with medicines and angioplasty or surgery may be eligible for this study. Those enrolled will receive monetary compensation for their participation in this study. The duration of the study is 5 days, with 2 testing periods lasting 2 days each. During one of the periods, the study participants will breathe nitric oxide mixed with room air through a face mask during the tests. During the other period, the participants will breathe room air alone through a face mask during the tests. At least 1 day will separate the treatment periods. During each of the 2 treatment periods (nitric oxide and room air), participants will undergo 4 tests to determine whether the treatment improves the heart's response to stress with increased heart rate and contraction. Approximately one hour before each of the tests, participants will breathe either nitric oxide mixed with room air or room air alone through the face mask, and continue the inhalation treatment while each test is being performed. The face mask will be removed at the end of each test. On the morning of the first day of each treatment period, participants will have a special echocardiogram with imaging of the heart. The echocardiogram will be performed during an infusion of dobutamine, a medicine that increases heart rate and contraction, and serves to stress the heart. This manner of stress testing is commonly used in hospitals around the country to determine if walls of the heart are receiving sufficient blood supply. That afternoon, participants will undergo a magnetic resonance imaging (MRI) study of the heart. The MRI will determine the heart's blood flow and contraction while receiving the same dosage of dobutamine as was used earlier in the day. On the morning of the second day of each treatment period, participants will exercise on a treadmill until moderately uncomfortable chest pain is reported. Later that morning, participants will undergo cardiac catheterization. For the cardiac catheterization, a long tube (catheter) will be placed into a vein of the neck once the skin is numbed with xylocaine. This tube will be positioned within the right atrium of the heart and into a tube-like structure called the coronary sinus, where venous blood exits the heart muscle. A small catheter will also be placed in an artery of the upper forearm after the skin has been numbed with xylocaine. Blood samples will be taken to allow us to measure the amount of nitric oxide transported in the blood. The blood samples will be drawn (through the tube in the heart and through the small tube in the artery) at the beginning of the study and during infusion of dobutamine to stress the heart. The dose of the dobutamine infusion will be the same dose used in the previous day's stress studies. After the completion of the first treatment period, we will stop testing for at least one day. Participants will begin the second treatment period with the inhalation treatment not received during the first treatment period. Detailed Description Although medical therapy and revascularization procedures are effective for relief of chest pain symptoms in many patients with coronary artery disease (CAD), others either do not respond to or tolerate medical therapies, or have failed attempts at revascularization. For this growing number of patients, there is a need for novel therapeutic approaches. The purpose of this protocol is to test the effectiveness of nitric oxide (NO) inhalation therapy for the relief of inducible myocardial ischemia in patients with CAD who have failed conventional attempts at medical and revascularization management. Our hypothesis is that enriched NO transport in blood from the lungs and delivery to the coronary vasculature with NO inhalation will improve blood flow to the myocardium during stress by dilating coronary arteries and arterioles. The primary end-point of this study is improvement in treadmill exercise duration during NO inhalation compared with exercise duration during room air breathing, with secondary end-points selected to provide mechanistic insight as to relief of inducible ischemia by NO, including effects on: 1) arterial delivery and myocardial extraction of NO transport molecules, 2) myocardial perfusion, and 3) global and regional myocardial contractility. This clinical trial is randomized, double-blind, and placebo (room air)-controlled in design, with CAD patients treated with NO (or room air) breathing for approximately 1 hour before each stress test, followed by crossover to the alternate therapy after two days of testing. Demonstration of benefit from NO inhalation could result in an important therapeutic option for CAD patients with few alternatives for the relief of myocardial ischemia. More... »

URL

https://clinicaltrials.gov/show/NCT00014040

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/3048", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/3053", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "type": "DefinedTerm"
      }
    ], 
    "description": "This study will test whether inhaling nitric oxide gas can improve blood flow to the heart, ventricular function, exercise tolerance in patients with coronary artery disease and chest pain that has not improved with medical or surgical therapy. Patients with coronary artery disease who have chest pain despite treatment with medicines and angioplasty or surgery may be eligible for this study. Those enrolled will receive monetary compensation for their participation in this study. The duration of the study is 5 days, with 2 testing periods lasting 2 days each. During one of the periods, the study participants will breathe nitric oxide mixed with room air through a face mask during the tests. During the other period, the participants will breathe room air alone through a face mask during the tests. At least 1 day will separate the treatment periods. During each of the 2 treatment periods (nitric oxide and room air), participants will undergo 4 tests to determine whether the treatment improves the heart's response to stress with increased heart rate and contraction. Approximately one hour before each of the tests, participants will breathe either nitric oxide mixed with room air or room air alone through the face mask, and continue the inhalation treatment while each test is being performed. The face mask will be removed at the end of each test. On the morning of the first day of each treatment period, participants will have a special echocardiogram with imaging of the heart. The echocardiogram will be performed during an infusion of dobutamine, a medicine that increases heart rate and contraction, and serves to stress the heart. This manner of stress testing is commonly used in hospitals around the country to determine if walls of the heart are receiving sufficient blood supply. That afternoon, participants will undergo a magnetic resonance imaging (MRI) study of the heart. The MRI will determine the heart's blood flow and contraction while receiving the same dosage of dobutamine as was used earlier in the day. On the morning of the second day of each treatment period, participants will exercise on a treadmill until moderately uncomfortable chest pain is reported. Later that morning, participants will undergo cardiac catheterization. For the cardiac catheterization, a long tube (catheter) will be placed into a vein of the neck once the skin is numbed with xylocaine. This tube will be positioned within the right atrium of the heart and into a tube-like structure called the coronary sinus, where venous blood exits the heart muscle. A small catheter will also be placed in an artery of the upper forearm after the skin has been numbed with xylocaine. Blood samples will be taken to allow us to measure the amount of nitric oxide transported in the blood. The blood samples will be drawn (through the tube in the heart and through the small tube in the artery) at the beginning of the study and during infusion of dobutamine to stress the heart. The dose of the dobutamine infusion will be the same dose used in the previous day's stress studies. After the completion of the first treatment period, we will stop testing for at least one day. Participants will begin the second treatment period with the inhalation treatment not received during the first treatment period.\n\nDetailed Description\nAlthough medical therapy and revascularization procedures are effective for relief of chest pain symptoms in many patients with coronary artery disease (CAD), others either do not respond to or tolerate medical therapies, or have failed attempts at revascularization. For this growing number of patients, there is a need for novel therapeutic approaches. The purpose of this protocol is to test the effectiveness of nitric oxide (NO) inhalation therapy for the relief of inducible myocardial ischemia in patients with CAD who have failed conventional attempts at medical and revascularization management. Our hypothesis is that enriched NO transport in blood from the lungs and delivery to the coronary vasculature with NO inhalation will improve blood flow to the myocardium during stress by dilating coronary arteries and arterioles. The primary end-point of this study is improvement in treadmill exercise duration during NO inhalation compared with exercise duration during room air breathing, with secondary end-points selected to provide mechanistic insight as to relief of inducible ischemia by NO, including effects on: 1) arterial delivery and myocardial extraction of NO transport molecules, 2) myocardial perfusion, and 3) global and regional myocardial contractility. This clinical trial is randomized, double-blind, and placebo (room air)-controlled in design, with CAD patients treated with NO (or room air) breathing for approximately 1 hour before each stress test, followed by crossover to the alternate therapy after two days of testing. Demonstration of benefit from NO inhalation could result in an important therapeutic option for CAD patients with few alternatives for the relief of myocardial ischemia.", 
    "endDate": "2003-04-01T00:00:00Z", 
    "id": "sg:clinicaltrial.NCT00014040", 
    "keywords": [
      "nitric oxide inhalation", 
      "Myocardial Ischemia", 
      "coronary artery disease", 
      "nitric oxide", 
      "blood flow", 
      "heart", 
      "ventricular function", 
      "exercise tolerance", 
      "patient", 
      "chest pain", 
      "surgical therapy", 
      "medicine", 
      "angioplasty", 
      "General Surgery", 
      "participation", 
      "duration", 
      "period", 
      "study participant", 
      "room air", 
      "face", 
      "treatment period", 
      "stress", 
      "increased heart rate", 
      "contraction", 
      "breathe", 
      "inhalation", 
      "echocardiogram", 
      "imaging", 
      "infusion", 
      "dobutamine", 
      "heart rate", 
      "stress testing", 
      "hospital", 
      "country", 
      "wall", 
      "blood supply", 
      "afternoon", 
      "Magnetic Resonance Imaging", 
      "dosage", 
      "exercise", 
      "treadmill", 
      "cardiac catheterization", 
      "tube", 
      "catheter", 
      "vein", 
      "neck", 
      "skin", 
      "lidocaine", 
      "Heart Atrium", 
      "coronary sinus", 
      "venous blood", 
      "myocardium", 
      "artery", 
      "forearm", 
      "blood sample", 
      "blood", 
      "small tube", 
      "beginning", 
      "dose", 
      "same dose", 
      "completion", 
      "stop", 
      "second treatment", 
      "medical therapy", 
      "revascularization procedure", 
      "relief", 
      "pain symptom", 
      "revascularization", 
      "novel therapeutic approach", 
      "protocol", 
      "effectiveness", 
      "Respiratory Therapy", 
      "lung", 
      "delivery", 
      "coronary vasculature", 
      "arteriole", 
      "primary end point", 
      "improvement", 
      "treadmill exercise", 
      "exercise duration", 
      "air breathing", 
      "Secondary end point", 
      "mechanistic insight", 
      "ischemia", 
      "extraction", 
      "transport molecule", 
      "myocardial perfusion", 
      "myocardial contractility", 
      "clinical trial", 
      "placebo", 
      "coronary artery disease patient", 
      "respiration", 
      "alternate therapy", 
      "demonstration", 
      "benefit", 
      "therapeutic option", 
      "alternative"
    ], 
    "name": "Nitric Oxide Inhalation Therapy for Myocardial Ischemia in Patients With Coronary Artery Disease", 
    "sameAs": [
      "https://app.dimensions.ai/details/clinical_trial/NCT00014040"
    ], 
    "sdDataset": "clinical_trials", 
    "sdDatePublished": "2019-03-07T15:21", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "file:///pack/app/us_ct_data_00000.json", 
    "sponsor": [
      {
        "id": "https://www.grid.ac/institutes/grid.410305.3", 
        "type": "Organization"
      }, 
      {
        "id": "https://www.grid.ac/institutes/grid.279885.9", 
        "type": "Organization"
      }
    ], 
    "startDate": "2001-04-01T00:00:00Z", 
    "subjectOf": [
      {
        "id": "sg:pub.10.1038/327524a0", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1025944311", 
          "https://doi.org/10.1038/327524a0"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/288373a0", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1035626789", 
          "https://doi.org/10.1038/288373a0"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/333664a0", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1042029444", 
          "https://doi.org/10.1038/333664a0"
        ], 
        "type": "CreativeWork"
      }
    ], 
    "type": "MedicalStudy", 
    "url": "https://clinicaltrials.gov/show/NCT00014040"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/clinicaltrial.NCT00014040'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/clinicaltrial.NCT00014040'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/clinicaltrial.NCT00014040'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/clinicaltrial.NCT00014040'


 

This table displays all metadata directly associated to this object as RDF triples.

133 TRIPLES      16 PREDICATES      117 URIs      106 LITERALS      1 BLANK NODES

Subject Predicate Object
1 sg:clinicaltrial.NCT00014040 schema:about anzsrc-for:3048
2 anzsrc-for:3053
3 schema:description This study will test whether inhaling nitric oxide gas can improve blood flow to the heart, ventricular function, exercise tolerance in patients with coronary artery disease and chest pain that has not improved with medical or surgical therapy. Patients with coronary artery disease who have chest pain despite treatment with medicines and angioplasty or surgery may be eligible for this study. Those enrolled will receive monetary compensation for their participation in this study. The duration of the study is 5 days, with 2 testing periods lasting 2 days each. During one of the periods, the study participants will breathe nitric oxide mixed with room air through a face mask during the tests. During the other period, the participants will breathe room air alone through a face mask during the tests. At least 1 day will separate the treatment periods. During each of the 2 treatment periods (nitric oxide and room air), participants will undergo 4 tests to determine whether the treatment improves the heart's response to stress with increased heart rate and contraction. Approximately one hour before each of the tests, participants will breathe either nitric oxide mixed with room air or room air alone through the face mask, and continue the inhalation treatment while each test is being performed. The face mask will be removed at the end of each test. On the morning of the first day of each treatment period, participants will have a special echocardiogram with imaging of the heart. The echocardiogram will be performed during an infusion of dobutamine, a medicine that increases heart rate and contraction, and serves to stress the heart. This manner of stress testing is commonly used in hospitals around the country to determine if walls of the heart are receiving sufficient blood supply. That afternoon, participants will undergo a magnetic resonance imaging (MRI) study of the heart. The MRI will determine the heart's blood flow and contraction while receiving the same dosage of dobutamine as was used earlier in the day. On the morning of the second day of each treatment period, participants will exercise on a treadmill until moderately uncomfortable chest pain is reported. Later that morning, participants will undergo cardiac catheterization. For the cardiac catheterization, a long tube (catheter) will be placed into a vein of the neck once the skin is numbed with xylocaine. This tube will be positioned within the right atrium of the heart and into a tube-like structure called the coronary sinus, where venous blood exits the heart muscle. A small catheter will also be placed in an artery of the upper forearm after the skin has been numbed with xylocaine. Blood samples will be taken to allow us to measure the amount of nitric oxide transported in the blood. The blood samples will be drawn (through the tube in the heart and through the small tube in the artery) at the beginning of the study and during infusion of dobutamine to stress the heart. The dose of the dobutamine infusion will be the same dose used in the previous day's stress studies. After the completion of the first treatment period, we will stop testing for at least one day. Participants will begin the second treatment period with the inhalation treatment not received during the first treatment period. Detailed Description Although medical therapy and revascularization procedures are effective for relief of chest pain symptoms in many patients with coronary artery disease (CAD), others either do not respond to or tolerate medical therapies, or have failed attempts at revascularization. For this growing number of patients, there is a need for novel therapeutic approaches. The purpose of this protocol is to test the effectiveness of nitric oxide (NO) inhalation therapy for the relief of inducible myocardial ischemia in patients with CAD who have failed conventional attempts at medical and revascularization management. Our hypothesis is that enriched NO transport in blood from the lungs and delivery to the coronary vasculature with NO inhalation will improve blood flow to the myocardium during stress by dilating coronary arteries and arterioles. The primary end-point of this study is improvement in treadmill exercise duration during NO inhalation compared with exercise duration during room air breathing, with secondary end-points selected to provide mechanistic insight as to relief of inducible ischemia by NO, including effects on: 1) arterial delivery and myocardial extraction of NO transport molecules, 2) myocardial perfusion, and 3) global and regional myocardial contractility. This clinical trial is randomized, double-blind, and placebo (room air)-controlled in design, with CAD patients treated with NO (or room air) breathing for approximately 1 hour before each stress test, followed by crossover to the alternate therapy after two days of testing. Demonstration of benefit from NO inhalation could result in an important therapeutic option for CAD patients with few alternatives for the relief of myocardial ischemia.
4 schema:endDate 2003-04-01T00:00:00Z
5 schema:keywords General Surgery
6 Heart Atrium
7 Magnetic Resonance Imaging
8 Myocardial Ischemia
9 Respiratory Therapy
10 Secondary end point
11 afternoon
12 air breathing
13 alternate therapy
14 alternative
15 angioplasty
16 arteriole
17 artery
18 beginning
19 benefit
20 blood
21 blood flow
22 blood sample
23 blood supply
24 breathe
25 cardiac catheterization
26 catheter
27 chest pain
28 clinical trial
29 completion
30 contraction
31 coronary artery disease
32 coronary artery disease patient
33 coronary sinus
34 coronary vasculature
35 country
36 delivery
37 demonstration
38 dobutamine
39 dosage
40 dose
41 duration
42 echocardiogram
43 effectiveness
44 exercise
45 exercise duration
46 exercise tolerance
47 extraction
48 face
49 forearm
50 heart
51 heart rate
52 hospital
53 imaging
54 improvement
55 increased heart rate
56 infusion
57 inhalation
58 ischemia
59 lidocaine
60 lung
61 mechanistic insight
62 medical therapy
63 medicine
64 myocardial contractility
65 myocardial perfusion
66 myocardium
67 neck
68 nitric oxide
69 nitric oxide inhalation
70 novel therapeutic approach
71 pain symptom
72 participation
73 patient
74 period
75 placebo
76 primary end point
77 protocol
78 relief
79 respiration
80 revascularization
81 revascularization procedure
82 room air
83 same dose
84 second treatment
85 skin
86 small tube
87 stop
88 stress
89 stress testing
90 study participant
91 surgical therapy
92 therapeutic option
93 transport molecule
94 treadmill
95 treadmill exercise
96 treatment period
97 tube
98 vein
99 venous blood
100 ventricular function
101 wall
102 schema:name Nitric Oxide Inhalation Therapy for Myocardial Ischemia in Patients With Coronary Artery Disease
103 schema:sameAs https://app.dimensions.ai/details/clinical_trial/NCT00014040
104 schema:sdDatePublished 2019-03-07T15:21
105 schema:sdLicense https://scigraph.springernature.com/explorer/license/
106 schema:sdPublisher Na3ada5e1d0664616a5bbea2797ff87c0
107 schema:sponsor https://www.grid.ac/institutes/grid.279885.9
108 https://www.grid.ac/institutes/grid.410305.3
109 schema:startDate 2001-04-01T00:00:00Z
110 schema:subjectOf sg:pub.10.1038/288373a0
111 sg:pub.10.1038/327524a0
112 sg:pub.10.1038/333664a0
113 schema:url https://clinicaltrials.gov/show/NCT00014040
114 sgo:license sg:explorer/license/
115 sgo:sdDataset clinical_trials
116 rdf:type schema:MedicalStudy
117 Na3ada5e1d0664616a5bbea2797ff87c0 schema:name Springer Nature - SN SciGraph project
118 rdf:type schema:Organization
119 anzsrc-for:3048 schema:inDefinedTermSet anzsrc-for:
120 rdf:type schema:DefinedTerm
121 anzsrc-for:3053 schema:inDefinedTermSet anzsrc-for:
122 rdf:type schema:DefinedTerm
123 sg:pub.10.1038/288373a0 schema:sameAs https://app.dimensions.ai/details/publication/pub.1035626789
124 https://doi.org/10.1038/288373a0
125 rdf:type schema:CreativeWork
126 sg:pub.10.1038/327524a0 schema:sameAs https://app.dimensions.ai/details/publication/pub.1025944311
127 https://doi.org/10.1038/327524a0
128 rdf:type schema:CreativeWork
129 sg:pub.10.1038/333664a0 schema:sameAs https://app.dimensions.ai/details/publication/pub.1042029444
130 https://doi.org/10.1038/333664a0
131 rdf:type schema:CreativeWork
132 https://www.grid.ac/institutes/grid.279885.9 schema:Organization
133 https://www.grid.ac/institutes/grid.410305.3 schema:Organization
 




Preview window. Press ESC to close (or click here)


...